Print ISSN: 2393-9079
Online ISSN: 2393-9087
CODEN : IJPPTK
Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...Original Article
Author Details :
Volume : 5, Issue : 3, Year : 2018
Article Page : 135-140
https://doi.org/10.18231/2393-9087.2018.0029
Abstract
In the present study the ethanolic extract of Aquilaria malaccensis (Agar wood) leaves before inoculation (BF) and after inoculation (AF)) was evaluated for its anticancer potentials. The leaf extracts (BF and AF) was subjected to in-vitro cytotoxicity studies on EAC cells, normal spleen cells and DLA cells. The leaf extracts showed dose dependent cytotoxicity with increase in dose. The IC50 value for BF and the AF leaf extract was 79.09?g/ml and 79.20?g/ml respectively. The effect on primary spleen cells was observed to be more than 100?g/ml. The study concluded that the extract of the said plant leaves has significant potential anti-cancer activity. All these results clearly indicate that the crude extract has a remarkable capacity to inhibit the growth of Ascites tumor induced by EAC cell line in animals.
Keywords: Anti-cancer, Aquilaria malaccensis, EAC cell line.
How to cite : Hegde K, Fathima Jazeela M A, Vijetha Poojary K, Satish S, Anti-Cancer potentials of the plant Aquilaria malaccensis leaves. Indian J Pharm Pharmacol 2018;5(3):135-140
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.